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Abstract
Background. Cuff blood pressure (BP) measurement has been the standard method for taking BP in routine daily 
practice for more than a century. However, some concerns were raised about the accuracy of this method which could 
lead to misclassification of BP in many situations. 
We aimed primarily to confirm a recent major discovery that distinct BP phenotypes based on central-to-peripheral 
systolic blood pressure (SBP) amplification do exist, and whether application of a validated cuff BP method (e.g. 
oscillometric) could accurately discriminate these differences. 
Material and methods. Among 106 participants (mean age 62 ± 11; 58% males) undergoing coronary angiography, 
intra-arterial BP was measured at 3 points (ascending aorta, brachial and radial arteries). Central-to-peripheral SBP 
amplification (SBPamp) was defined as ≥ 5 mm Hg SBP increased from aorta-to-brachial and/or from brachial-to- 
-radial arteries. A validated cuff BP device (oscillometric) was used to measure BP at 4 different time points. 
Results. Four different BP phenotypes were confirmed based on the magnitude of SBPamp; phenotype I, both 
aortic-to brachial and brachial-to radial SBPamp; phenotype II, only aortic-to-brachial SBPamp; phenotype III, only 
brachial-to-radial SBPamp; and phenotype IV, no SBPamp at all. Aortic SBP was significantly higher in phenotypes-
III and IV compared to phenotypes-I and II (p = 0.001). This was not discriminated using a validated cuff BP device 
measurement (p = 0.996). Results for the pulse pressure (PP) followed the same pattern. 
Conclusion. Distinct BP phenotypes do exist based on SBPamp. A validated cuff BP method failed to discriminate 
this. Improving quality of BP measurements in daily practice is a priority.
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Introduction
Blood pressure (BP) measurement in a proper way 
is regarded as one of the most important measure-
ments in daily clinical practice [1]. This is because 
accurate diagnosis of hypertension (HTN), accom-
panied by lifestyle modifications (with or without 
anti-hypertensive medications) can lead to substan-
tial reductions of the future cardiovascular (CV) risk 
[2]. Despite many concerns raised about the accuracy 
of cuff BP measurements used in daily practice [3], 
this method has not changed significantly over the 
past century. Thanks to a recent individual patient 
data systematic review and meta-analysis [4], it has 
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been shown that routinely used cuff BP devices are 
exposed to inaccuracies when compared to intra-arte-
rial (invasive) BP values, especially for systolic blood 
pressure (SBP) in the range of 120–159 mm Hg. 
Accordingly, this could have huge implications on 
how HTN is correctly diagnosed in the first place.
Cuff BP devices (both oscillometric and standard 
Korotkoff sounds) use arterial signals at an isolated 
point in a peripheral artery (usually the brachial ar-
tery) to measure BP [5, 6]. However, there are large 
inter-individual variability in arterial characteristics 
(e.g. stiffness, diameter, etc.) and in the way BP is 
transmitted from central-to-peripheral vasculature 
(e.g. increased SBP amplification in some, but not 
in others) [7–10]. Therefore, measuring BP at an 
isolated arterial point may overlook these fine phe-
notypic differences.
This notion has been recently raised by Picone 
et al [11], who discovered for the first time that 
there are 4 distinctive phenotypes of BP (based on 
central-to-peripheral SBP amplification as measured 
invasively), and that these different phenotypes were 
not discriminated at all by cuff BP devices used in 
daily routine practice. Importantly, they cautioned 
that these findings may not be generalizable to other 
patients beyond their study population and that fu-
ture research is warranted to corroborate these find-
ings and to test whether such phenotypes would be 
present among sample populations other than those 
examined in their work. Therefore, we found that it 
may be of considerable interest if we could replicate 
these novel findings among a group of patients with 
different ethnicity and characteristics.
Material and methods
Study subjects
In the period from November 2018 to April 2019, 
this observational study included patients with a clin-
ical indication for coronary angiography at National 
Heart Institute, Giza, Egypt. Among 181 patients 
screened, seventy-five patients were excluded leaving 
106 eligible patients for study procedures. Patients 
were excluded with the following criteria that may 
introduce errors in intra-arterial BP measurement; 
atrial fibrillation or aortic stenosis (n = 16); a cuff BP 
inter-arm difference of > 5 mm Hg (n = 8); inability 
to measure BP in both arms for whatever reason 
(n = 10); use of femoral arterial access for coronary 
angiography (due to inaccessibility of upper limb ar-
teries; n = 11). We also excluded patients with medi-
cal (radial artery spasm; n = 6) or technical issues that 
detracted the quality of pressure waveforms recorded 
(n = 5). Nineteen patients did not provide a consent. 
Included patients’ clinical characteristics including 
anthropometric measures and clinical history were 
recorded at the angiography preassessment (usually 
1 day before the procedure) by nursing staff. Other 
clinical information was extracted from the hospital 
medical records. The study was approved by the local 
ethical committee and all participants provided an 
informed consent.
Intra-arterial BP measurement
The right radial artery was used for catheter access. 
All patients were examined under stable haemody-
namics without moving or talking. They were also 
devoid of any medications that could induce an acute 
vasoactive response as per the ARTERY guidelines 
(Association for Research into Arterial Structure and 
Physiology) [12]. After the clinical procedure, intra-
arterial BP was measured with a fluid-filled system 
using 5F (18% of cases) and 6F (82% of cases) 
catheters, including a 5–6F Judkins Left (Cordis) 
and 5–6F Multipurpose (Cordis) catheters. Fluoros-
copy was used to confirm the catheter position at 
each arterial site and the catheter was flushed before 
all waveform recordings. Stable pressure waveforms 
were recorded for a minimum of 20 seconds at each 
arterial site to reduce the influence of respiratory 
variation. Intra-arterial BP measurements began with 
the catheter in the proximal ascending aorta. The 
catheter was then pulled back to the upper arm 
(midhumerus) for brachial waveform measurement. 
Finally, the catheter was pulled back to the wrist, 
and the sheath was partially removed to allow the 
most distal radial waveform measurement possible. 
Waveforms were recorded via Dräger, Infinity® Delta 
series, Germany.
Cuff BP measurement
Because BP value may change over time, cuff BP 
was measured at 4 different time points (for each 
patient): first, during the angiography preassessment 
visit; second, in the waiting room before catheteriza-
tion, simultaneously on both arms with 2 identi-
cal devices; third, immediately before commencing 
the angiogram in the catheterization laboratory; and 
fourth, after the clinical procedure simultaneous with 
intra-arterial brachial BP. For all cuff measurements, 
participants were asked to remain still and quiet 
throughout the recordings. Cuff BP was measured 
with the automated oscillometric method using Om-
ron HEM-907 device (which has been validated ac-
cording to international protocols [13]). For cuff and 
intra-arterial measurements, pulse pressure (PP) was 
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calculated as SBP — diastolic BP. Mean arterial pres-
sure (MAP) was calculated as DBP + 1/3 PP. 
Defining BP phenotypes
As stated in Picone et al [11] methodology, the amount 
of SBP increase (SBP amplification) between the aorta-
to-brachial and brachial-to-radial arteries was used to 
define the BP phenotypes. When SBP increased by ≥ 5 
mm Hg between the aortic- to-brachial or brachial-to-
radial arteries, this was considered an SBP amplifica-
tion. The threshold of 5 mm Hg was selected because 
it represents a difference in BP generally greater than 
what could be attributed to measurement variability 
[14, 15]. SBP increases of < 5 mm Hg between the 
aortic-to-brachial or brachial-to-radial arteries were 
not considered an SBP amplification. Phenotypic dif-
ferences’ delineation employs SBP specifically because 
SBP is more closely related to cardiovascular disease 
and outcomes compared with other BP indices [16, 
17]. Moreover, there is little variability in diastolic BP 
between the central-to-peripheral arteries [4].
Statistical analysis
Data management and statistical analysis were done 
using SPSS vs.25. (IBM, Armonk, New York, United 
States). Numerical data was summarized as means and 
standard deviations or medians and ranges. Categori-
cal data was summarized as numbers and percentages. 
Comparisons between four groups were done using 
One-way ANOVA or Kruskal-Wallis test for nor-
mally and non-normally distributed numerical vari-
ables respectively. Post hoc analysis was done in case 
of significant overall effect. All post hoc analysis was 
Bonferroni adjusted. Categorical data was compared 
using Chi-square test. All p values were two sided. 
P values less than 0.05 were considered significant.
Results
Study population
Generally, participants’ criteria were typically those 
of patients undergoing coronary catheterization: 
middle to older age (mean age 62 ± 11 years), with 
male gender preponderance (61%) and overweight to 
obese [mean body mass index (BMI) 30 ± 4 kg/m2]. 
Between-group analysis showed no statistically sig-
nificant differences in all baseline characteristics (ex-
cept for age) (Tab. I).
BP phenotypes and cuff BP values
Four different BP phenotypes were observed accord-
ing to the amount of aortic-to-brachial and brachial-
to-radial SBP amplification (Fig. 1):
Table I. Baseline characteristics of study population*
Phenotype I
(n = 27)
Phenotype II
(n = 29)
Phenotype III
(n = 26)
Phenotype IV
(n = 24)
p 
value
Age (years) Mean ± SD 56 ± 10a 58 ± 8a 69 ± 9b 68 ± 9b < 0.001
Gender
Males
n (%) 15 (55.6) 19 (65.5) 14 (53.8) 13 (54.2) 0.788
Females
n (%) 12 (44.4) 10 (34.5) 12 (46.2) 11 (45.8)
Hypertension Yesn (%) 18 (66.7) 18 (62.1) 16 (61.5) 16 (66.7) 0.965
Diabetes Yesn (%) 12 (44.4) 12 (41.4) 12 (46.2) 10 (41.7) 0.982
Smoking Yes n (%) 10 (37.0) 12 (41.4) 10 (38.5) 10 (41.7) 0.982
Obesity Yesn (%) 8 (29.6) 9 (31.0) 8 (30.8) 8 (33.3) 0.994
BMI [kg/m2] Mean ± SD 30 ±4 30 ±3 30 ±3 31 ±5 0.845
Known dyslipidaemia Yesn (%) 5 (18.5) 6 (20.7) 5 (19.2) 5 (20.8) 0.996
FH of premature CAD Yesn (%) 6 (22.2) 7 (24.1) 6 (23.1) 6 (25.0) 0.996
PH of CVD Yes n (%) 20 (74.1) 23 (79.3) 20 (76.9) 18 (75.0) 0.97
*One-way ANOVA was used for age and BMI. Chi-square test was used for categorical data. Post hoc analysis was done in case of significant overall effect and different letters indicate significant pair. All post hoc were 
Bonferroni adjusted; BMI — body mass index; CAD — coronary artery disease; FH — family history; PH — past history; CVD — cardiovascular disease; SD — standard deviation
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• both aortic-to-brachial and brachial-to-aortic 
SBP amplification (≥ 5 mm Hg) in 27 patients 
(25.47%; phenotype I) (Fig. 2A);
• aortic-to-brachial but not brachial-to-radial SBP 
amplification in 29 patients (27.35%; pheno-
type II) (Fig. 2B);
• no aortic-to-brachial, but brachial-to-radial SBP 
amplification in 26 patients (24.52%; pheno-
type III) (Fig. 2C);
• neither aortic-to-brachial nor brachial-to-radial 
SBP amplification in 24 patients (22.64 %; phe-
notype IV) (Fig. 2D).
Aortic SBP was significantly different between the 
4 BP phenotypes (overall p value = 0.001) and was 
significantly higher in phenotypes-III and IV when 
compared to phenotype I (Fig. 3A; Tab. II). On the 
other hand, there was no statistically significant dif-
ferences between groups as regard brachial SBP (Fig. 
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Figure 1. Flow-chart of identification of various blood pressure (BP) phenotypes
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Figure 2. Case presentations of the 4 different blood pressure (BP) phenotypes based on differences in systolic blood pressure (SBP) 
amplification between aortic-to brachial and brachial-to-radial arteries. Recorded SBP is reported above each pressure waveform.  
A. Phenotype I (case no. 11), B. Phenotype II (case no. 3); C. Phenotype III (case no. 17); D. Phenotype IV (case no. 14)
Ahmed Bendary et al. Central-to-peripheral SBP different phenotypes
267www.ah.viamedica.pl
3A). Despite this marked variation in SBP amplifica-
tion from central-to-peripheral vasculature across the 
4 distinct BP phenotypes, there was no significant 
difference in standard cuff SBP measurements be-
tween the 4 groups (Tab. III). Of note, this lack of 
discrimination was consistent across all the 4 time 
points for cuff BP measurement and for the average 
of all cuff BP readings (p values > 0.50 for all com-
parisons; Fig. 3A; Tab. III).
Findings for PP followed the same pattern as for 
SBP; aortic PP was significantly different across the 
4 BP phenotypes (Fig. 3B; Tab. II), but cuff BP 
measurement did not discriminate this accurately 
whether measures at different time points of using 
the average of all cuff BP readings (p values > 0.30 
for all comparisons; Fig. 3B; Tab. III).
Discussion
To the best of our knowledge, this study is the 1st 
in the literature that reaffirms the major findings 
provided by Picone et al [11] who discovered the 
presence of 4 different BP phenotypes based on the 
magnitude of central-to-peripheral SBP amplifica-
tion. Notably, these various phenotypes were not 
discriminated by cuff BP measurements as used in 
routine daily practice. These findings make sense and 
imply that the practice of using standard one-for-all 
cuff BP devices should be revisited.
The clinical consequences of these findings are 
many, failure of a daily used cuff BP device to ac-
curately discriminate the higher intra-arterial SBP 
(and PP) among phenotypes III and IV (groups 
with little or no aortic-to-brachial SBP amplifica-
tion) could lead to misclassification of BP and po-
tentially missing the opportunity of implementing 
lifestyle changes or even initiating antihypertensive 
medications.
Table II. Haemodynamic parameters across the 4 study groups*
Group I
(n = 27)
Group II
(n = 29)
Group III
(n = 26)
Group IV
(n = 24) p value
Aortic SBP [mm Hg] Mean ± SD 122 ± 22a 126 ± 26a,c 140 ± 26b,c 146 ± 24b 0.001
Brachial SBP [mm Hg] Mean ± SD 139 ± 22 141 ± 28 139 ± 26 140 ± 26 0.988
Radial SBP [mm Hg] Mean ± SD 156 ± 29a 140 ± 29b,c 156 ± 39a,c 137 ± 25b,d 0.038
Aortic-to-brachial 
SBPamp [mm Hg]
Median 
(range) 15 (5–55)
a 10 (5–50)a 0 (–5–0)b 0 (–10–0)b < 0.001
Brachial-to radial 
SBPamp [mm Hg]
Median 
(range) 10 (5–60)
a 0 (–10–0)b 20 (5–60)a 0 (–5–2)b < 0.001
Aortic MAP [mm Hg] Mean ± SD 93 ± 16 93 ± 15 94 ± 16 92 ± 13 0.961
Aortic DBP [mm Hg] Mean ± SD 76 ± 16 74 ± 13 72 ± 13 73 ± 12 0.739
Aortic PP [mm Hg] Mean ± SD 46 ± 17 a 52 ± 21 a 73 ± 21 b 73 ± 28 b < 0.001
Brachial PP [mm Hg] Mean ± SD 62 ± 17 60 ± 24 62 ± 31 61 ± 28 0.997
Radial PP [mm Hg] Mean ± SD 77 ± 24 65 ± 26 79 ± 26 63 ± 30 0.05
Heart rate [bpm] Mean ± SD 80 ± 11 81 ± 9 80 ± 11 81 ± 10 0.978
*One-way ANOVA was used. Kruskal Wallis test was used for aortic to brachial SBPamp and brachial to radial SBPamp. Post hoc analysis was done in case of significant overall effect and different letters indicate signi-
ficant pair. All post hoc were Bonferroni adjusted; Bpm — beat per minute; DBP — diastolic blood pressure; MAP — mean arterial pressure; PP — pulse pressure; SBPamp — systolic blood pressure amplification
Figure 3. Cuff, intra-arterial aortic, and brachial blood pressure 
(BP) across the 4 BP phenotypes. A. Systolic BP (SBP); B. Pulse 
pressure (PP) — measured at the aorta (light bars), brachial artery 
(striated bars), and cuff BP measures (dark bars) across each BP 
phenotype. p values on the figure represent significant differences 
in aortic SBP and PP between the specific phenotypes. p > 0.05 
for all other comparisons. Data are mean ± SE of the mean
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Since aortic BP is more closely related to cardio-
vascular risk relative to upper arm BP values [18], 
we suggest that patients in phenotypes III and IV 
might be subjected to a higher future risk due to 
underestimation of high BP. However, the lack of 
amplification of SBP and PP may contribute to this 
risk more than the isolated value at a certain arte-
rial segment (e.g. aorta) as shown in some patients 
with end-stage renal disease [19]. On the other 
hand, it could be speculated that excessive SBP 
amplification itself may enhance end-organ damage 
at vulnerable sites but examining whether clinical 
outcomes would differ between various BP pheno-
types should be the focus of a prospective cohort 
study with a large sample size enabling the power 
to detect associations.
Of course, the mechanisms underlying differ-
ences between the 4 BP phenotypes were not ad-
dressed in the current study, but explanations do 
exist and are multifaceted. These differences may be 
related to the interplay between ventricular output 
(e.g. stroke volume, chronotropy and contractility), 
large conduit arterial wall characteristics (e.g. elas-
ticity) and criteria of small resistance arteries [20]. 
For instance, ejection of a good cardiac output into 
a healthy vascular system i.e. central arteries with 
good compliance that buffers the rapid increase in 
SBP, could lead to a downstream SBP augmenta-
tion considering the progressive peripheral taper-
ing of vessels coupled with decreased wall thick-
ness but increased stiffness [21]. On the contrary, 
lower ventricular inotropy and increased stiffness 
of central arteries relative to peripheral ones could 
lead to a high aortic SBP to a level that surpasses 
any peripheral amplification effect. This is more 
common with older age. Interestingly, patients in 
phenotypes-III and IV in the current study (groups 
with little or no peripheral SBP amplification) were 
significantly older than those in phenotypes-I and 
II (groups with high level of peripheral SBP ampli-
fication). 
Thus, considering this complex interplay underly-
ing the phenomenon of SBP amplification, it be-
comes unsurprising for cuff BP devices to be far less 
than accurate for dissecting these subtle differences 
using a one-size-for-all cuff methods. However, we 
Table III. Cuff blood pressure (BP) across the 4 study groups*
Group I
(n = 27)
Group II
(n = 29)
Group III
(n = 26)
Group IV
(n = 24) p value
Cuff SBP (pre-assessment) [mm Hg] 132 ± 24 133 ± 21 133 ± 22 131 ± 25 0.984
Cuff SBP (waiting room — left arm) 
[mm Hg] 131 ± 18 130 ± 16 133 ± 21 132 ± 24 0.976
Cuff SBP (waiting room — right arm) 
[mm Hg] 133 ± 18 132 ± 17 134 ± 21 131 ± 26 0.944
Cuff SBP (waiting room — average) 
[mm Hg] 132 ± 18 131 ± 16 133 ± 21 132 ± 24 0.981
Cuff SBP (pre-diagnostic cath)  
[mm Hg] 133 ± 17 131 ± 17 134 ± 22 133 ± 26 0.98
Cuff SBP (simultaneous with intra- 
-arterial brachial) [mm Hg] 138 ± 19 138 ± 27 137 ± 28 136 ± 31 0.993
Cuff SBP (average of all) [mm Hg] 133 ± 18 135 ± 15 134 ± 22 134 ± 24 0.996
Cuff PP (pre-assessment) [mm Hg] 52 ± 12 51 ± 13 54 ± 20 51 ± 12 0.814
Cuff PP (waiting room — left arm) 
[mm Hg] 52 ± 12 52 ± 13 55 ± 14 51 ± 15 0.651
Cuff PP (waiting room — right arm) 
[mm Hg] 55 ± 13 54 ± 13 57 ± 13 52 ± 13 0.534
Cuff PP (waiting room — average) 
[mm Hg] 53 ± 12 53 ± 12 57 ± 14 51 ± 15 0.472
Cuff PP (pre-diagnostic cath)  
[mm Hg] 54 ± 11 52 ± 13 57 ± 16 51 ± 13 0.503
Cuff PP (simultaneous with intra- 
-arterial brachial) [mm Hg] 57 ± 13 59 ± 20 57 ± 18 55 ± 20 0.889
Cuff PP (average of all) [mm Hg] 54 ± 10 53 ± 12 56 ± 13 53 ± 10 0.805
*One-way ANOVA was used. No post hoc analysis was done due to non-significant overall effect; PP — pulse pressure; SBP — systolic blood pressure
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should stress that this study (among others) is not 
meant at all to undermine the clinical value of cuff 
BP measurement, but rather suggests that develop-
ments could be applied to this method in order to 
improve its accuracy so that it could be used one day 
as a risk refinement tool.
Some limitations to this study deserve mention, 
first, we did not include a dedicated intra-arterial 
pressure waveform analysis device and we did not 
use multiple cuff devices for BP measurements due to 
limited resources and lack of fund. Second, we used 
a fluid-filled system rather than solid catheters for in-
tra-arterial BP measurement, and this may introduce 
few errors if the system was not carefully handled 
(for example, impingement of the arterial wall in 
small arteries). Finally, our findings are not generaliz-
able outside the examined population (patients with 
a clinical indication for coronary angiography). Hav-
ing said this, there is no compelling case that cuff BP 
devices would be necessarily inaccurate among all pa-
tients. For example, the observed 4 phenotypes may 
be much less distinct among younger healthy people 
with less advancing age and no disease affecting the 
vascular system such as diabetes. However, this is to 
be examined in further large-scale cohort studies.
Conclusion
This study confirms that distinct intra-arterial BP 
phenotypes do exist based on SBP central-to-pe-
ripheral amplification. A daily used validated cuff 
BP method failed to discriminate this. Improving 
quality of BP measurements in routine practice by 
taking this phenotypic variation into account should 
be a future research focus.
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